Levetiracetam for Phasic Spasticity in Multiple Sclerosis

Archives of Neurology

Volumn 60, Issue 12, 2003, Pages 1772-1774

  Hawker, Kathleen ^a   Frohman, Elliot ^a   Racke, Michael ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; DANTROLENE; ETIRACETAM; GABAPENTIN; PLACEBO; TIZANIDINE;

ADULT; AMNESIA; ARTICLE; BALANCE DISORDER; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFUSION; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; FEMALE; FOLLOW UP; HUMAN; LIVER TOXICITY; MALE; MEDICAL RECORD; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; NEUROPATHIC PAIN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SEDATION; SIDE EFFECT; SOMNOLENCE; SPASTICITY; SYMPTOM; THOUGHT DISORDER; UNITED STATES;

ADULT; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; PIRACETAM; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0346754901     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.12.1772     Document Type: Article

References (19)

1. Lance, JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, eds. Spasticity: Disordered Motor Control. Chicago, III: Year Book Medical Publishers; 1980:485-494.
2. Nuyens G, De Weerdt W, Mertin J. Spasticity. In: Keteaer P, Prosiegel M, Battaglia M, Messmer Uccelli M, eds. A Problem-Orientated Approach to Multiple Sclerosis. Leuven, Belgium: Acco Press; 1997:199-201.
3. Schapiro RT. Symptomatic therapy. In: Cook S, ed. Handbook of Multiple Sclerosis. 3rd ed: New York, NY: Marcel Dekker Inc; 2001:601-608.
4. Schapiro RT, Schneider DM. Spasticity, balance, tremor, and weakness: factors in mobility impairment. In: van den Noort S, Holland N. eds. Multiple Sclerosis in Clinical Practice. New York, NY: Demos Medical Publishing; 1999:41-56.
5. Kita M, Goodkin DE. Drugs used to treat spasticity. Drugs. 2000;59:487-495.
6. Francisco GE, Kothari S, Huls C. GABA agonists and gabapentin for spastic hypertonia. Phys Med Rehabil Clin N Am. 2601;12:875-888.
7. Cutter NC, Scott DD, Johnson JC, Whiteneck G. Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial. Arch Phys Med Rehabil. 2000;81:164-169.
8. Rigo JM, Hans G, Nguyen L, et al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycmegated currents. Br J Pharmacol. 2002;136:659-672.
9. Lukyanetz EA, Shkryl VM, Kostyuk PG. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia. 2002;43:9-18.
10. Jenson MG, Royal MA, Mowa V, Ward S. Gabapentin and levetiracetam for the treatment of neuropathic pain: a prospective open-label trial. Am J Pain Manag. 2001;11:125-128.
11. Ardid D, Lamberty Y, Alloui A, Eschalier A. Levetiracetam (Keppra), a new antiepileptic drug, is effective in neuropathic but not acute pain models in rats [abstract]. Neurology. 2001;56(suppl 3):A351.
12. Harden C. Safety profile of levetiracetam. Epilepsia. 2001;42(suppl 4):36-39.
13. French J, Edrich P, Cramer JA. A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. Epilepsy Res. 2001;47:77-90.
14. Cramer JA, Arrigo C, Van Hammée G, Gauer LJ, Cereghino JJ. Effect of levetiracetam on epilepsy-related quality of life. Epilepsia. 2000;41:868-874.
15. Patsalos PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther. 2000;85:77-85.
16. DeSousa EA, Albert RH, Kalman B. Cognitive impairments in multiple sclerosis: a review. Am J Alzheimers Dis Other Demen. 2002;17:23-29.
17. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 1964;192:540-542.
18. Backonja M-M. Anticonvulsants (antineuropathics) for neuropathic pain syndromes. Clin J Pain. 2000;16(suppl 2):S67-S72.
19. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2002;2:CD002067.